CARIS LIFE SCIENCES, INC. Interest Income, Other
CARIS LIFE SCIENCES, INC. (CAI) reported Interest Income, Other of $6.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. interest income, other for the quarter ending 2026-06-30 was $6.82M, a 321.45% increase year-over-year.
- CARIS LIFE SCIENCES, INC. interest income, other for the quarter ending 2026-03-31 was $6.83M, a 1258.65% increase year-over-year.
- CARIS LIFE SCIENCES, INC. interest income, other for the quarter ending 2025-12-31 was $7.01M, a 623.20% increase year-over-year.
- CARIS LIFE SCIENCES, INC. interest income, other for the quarter ending 2025-09-30 was $7.36M, a 322.02% increase year-over-year.
- CARIS LIFE SCIENCES, INC. interest income, other for fiscal 2025 was $16.50M, a 131.63% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. interest income, other for fiscal 2024 was $7.12M, a 36.74% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. interest income, other for fiscal 2023 was $11.26M.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.82M 10-Q · filed 2026-08-05 | $13.65M 10-Q · filed 2026-08-05 | $20.67M derived: sum of 3 quarters · filed 2026-08-05 | $28.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $6.83M 10-Q · filed 2026-05-08 | $13.85M derived: sum of 2 quarters · filed 2026-05-08 | $21.21M derived: sum of 3 quarters · filed 2026-05-08 | $22.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $14.38M derived: sum of 2 quarters · filed 2026-03-03 | $15.99M derived: sum of 3 quarters · filed 2026-08-05 | $16.50M 10-K · filed 2026-03-03 |
| 2025-09-30 | $7.36M 10-Q · filed 2025-11-05 | $8.98M derived: sum of 2 quarters · filed 2026-08-05 | $9.48M 10-Q · filed 2025-11-05 | $10.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.62M 10-Q · filed 2026-08-05 | $2.12M 10-Q · filed 2026-08-05 | $3.09M derived: sum of 3 quarters · filed 2026-08-05 | $4.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $503.00K 10-Q · filed 2026-05-08 | $1.47M derived: sum of 2 quarters · filed 2026-05-08 | $3.22M derived: sum of 3 quarters · filed 2026-05-08 | $5.86M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $970.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.71M derived: sum of 2 quarters · filed 2026-03-03 | $5.35M derived: sum of 3 quarters · filed 2026-03-03 | $7.12M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.74M 10-Q · filed 2025-11-05 | $4.38M derived: sum of 2 quarters · filed 2025-11-05 | $6.15M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $2.64M 10-Q · filed 2025-08-12 | $4.41M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $11.26M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |